First Time Loading...

Samsung Biologics Co Ltd
KRX:207940

Watchlist Manager
Samsung Biologics Co Ltd Logo
Samsung Biologics Co Ltd
KRX:207940
Watchlist
Price: 745 000 KRW -1.32%
Updated: May 29, 2024

Samsung Biologics Co Ltd
Accounts Payable

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Samsung Biologics Co Ltd
Accounts Payable Peer Comparison

Comparables:
P
087010
S
237690
F
220100
L
141080
C
268600

Competitive Accounts Payable Analysis
Latest Figures & CAGR of Competitors

Company Accounts Payable CAGR 3Y CAGR 5Y CAGR 10Y
Samsung Biologics Co Ltd
KRX:207940
Accounts Payable
₩187.3B
CAGR 3-Years
66%
CAGR 5-Years
65%
CAGR 10-Years
N/A
P
Peptron Inc
KOSDAQ:087010
Accounts Payable
₩240.7m
CAGR 3-Years
-31%
CAGR 5-Years
3%
CAGR 10-Years
N/A
S
ST Pharm Co Ltd
KOSDAQ:237690
Accounts Payable
₩17.7B
CAGR 3-Years
32%
CAGR 5-Years
29%
CAGR 10-Years
N/A
F
FutureChem Co Ltd
KOSDAQ:220100
Accounts Payable
₩246.5m
CAGR 3-Years
-36%
CAGR 5-Years
-18%
CAGR 10-Years
N/A
L
LegoChem Biosciences Inc
KOSDAQ:141080
Accounts Payable
₩7.1B
CAGR 3-Years
3%
CAGR 5-Years
-3%
CAGR 10-Years
N/A
C
Cellivery Therapeutics Inc
KOSDAQ:268600
Accounts Payable
₩1.2B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Samsung Biologics Co Ltd's Accounts Payable?
Accounts Payable
187.3B KRW

Based on the financial report for Mar 31, 2024, Samsung Biologics Co Ltd's Accounts Payable amounts to 187.3B KRW.

What is Samsung Biologics Co Ltd's Accounts Payable growth rate?
Accounts Payable CAGR 5Y
65%

Over the last year, the Accounts Payable growth was 39%. The average annual Accounts Payable growth rates for Samsung Biologics Co Ltd have been 66% over the past three years , 65% over the past five years .